Cargando…
Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
OBJECTIVE: Bupropion, an antidepressant inhibiting the reuptake of dopamine and noradrenaline, should be useful to treat depressive symptoms in patients with Parkinson’s disease (PD). Limited and conflicting literature data questioned its effectiveness and safety in depressed PD patients and extende...
Autores principales: | Vismara, Matteo, Benatti, Beatrice, Nicolini, Gregorio, Cova, Ilaria, Monfrini, Edoardo, Di Fonzo, Alessio, Fetoni, Vincenza, Viganò, Caterina A., Priori, Alberto, Dell’Osso, Bernardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069850/ https://www.ncbi.nlm.nih.gov/pubmed/35513785 http://dx.doi.org/10.1186/s12883-022-02668-4 |
Ejemplares similares
-
Incidence and predictive factors of non adherence to therapy in young adults attending a psycho social center in Milan: a retrospective observational “Real world” study
por: Vanzetto, S., et al.
Publicado: (2022) -
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview
por: Vismara, Matteo, et al.
Publicado: (2020) -
Mental health evaluation of patients with Inflammatory Bowel Disease and psychiatric comorbidities during the COVID-19 pandemic
por: Vanzetto, S., et al.
Publicado: (2022) -
First vs second wave of COVID-19 pandemic in patients with obsessive compulsive disorder: A multicentre report from tertiary clinics in Northern Italy
por: Benatti, Beatrice, et al.
Publicado: (2022) -
Gender impact on the outcome of rehabilitation programs in psychiatry: Brief report from a metropolitan residential rehabilitative service
por: Cafaro, Rita, et al.
Publicado: (2023)